20 October 2025
Baker McKenzie Advises Lotus Pharmaceutical in Acquisition of Alvogen US
Advising firms
Deal team
44 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Lawrence Lee Lead | Baker McKenzie | Partner | M&A | Palo Alto |
| Hao-Ray Hu | Baker McKenzie | Partner | M&A | Taipei |
| Alex Chiang | Baker McKenzie | Partner | M&A | Taipei |
| Jean-François Findling | Baker McKenzie | Partner | M&A | Luxembourg |
| Emery Mitchell | Baker McKenzie | Partner | M&A | San Francisco |
| Fang-yi Jen | Baker McKenzie | Partner | M&A | Taipei |
| Louis Hsieh | Baker McKenzie | Partner | M&A | Taipei |
| Nicolas Clément | Baker McKenzie | Counsel | M&A | Luxembourg |
| Natasia Dumitru | Baker McKenzie | Counsel | M&A | Luxembourg |
| Gwen Karanadze | Baker McKenzie | Associate | M&A | New York |
| Devin Muntz | Baker McKenzie | Associate | M&A | Chicago |
| James Tenrai | Baker McKenzie | Associate | M&A | Palo Alto |
| Alyssa Dickinson | Baker McKenzie | Associate | M&A | San Francisco |
| Caroline Shih | Baker McKenzie | Associate | M&A | San Francisco |
| Aubrey Kelley | Baker McKenzie | Associate | M&A | New York |
| Bretton Stephenson | Baker McKenzie | Associate | M&A | Los Angeles |
| Elena Apopei | Baker McKenzie | Associate | M&A | Luxembourg |
| Jane Wu | Baker McKenzie | Associate | M&A | Taiwan |
| John Fedele | Baker McKenzie | Partner | Antitrust | Washington D.C. |
| Sylwia Lis | Baker McKenzie | Partner | Antitrust | Washington D.C. |
| Andrew Black | Baker McKenzie | Counsel | Antitrust | Washington D.C. |
| Evan Harris | Baker McKenzie | Associate | Antitrust | Washington D.C. |
| Thomas Asmar | Baker McKenzie | Partner | Benefits | Palo Alto |
| Sesen Hailemichael | Baker McKenzie | Associate | Benefits | San Francisco |
| Miju Damodar | Baker McKenzie | Partner | Banking and Finance | New York |
| Yanshu Zhang | Baker McKenzie | Associate | Banking and Finance | New York |
| Bee Leay Teo | Baker McKenzie | Other | Banking and Finance | Taipei |
| Yuci Hung | Baker McKenzie | Associate | Banking and Finance | Taiwan |
| Cynthia Cole | Baker McKenzie | Partner | IP | Palo Alto |
| Mackenzie Martin | Baker McKenzie | Partner | IP | Dallas |
| DJ Lee | Baker McKenzie | Associate | IP | Dallas |
| Richard Yang | Baker McKenzie | Associate | IP | Palo Alto |
| Mark Goodman | Baker McKenzie | Partner | Litigation | San Francisco |
| Barry Thompson | Baker McKenzie | Partner | Litigation | Los Angeles |
| Tom Tysowsky | Baker McKenzie | Associate | Litigation | Los Angeles |
| Henna Bhandal | Baker McKenzie | Associate | Litigation | Los Angeles |
| Ina Jheng | Baker McKenzie | Associate | Litigation | Taipei |
| Amanda Cohen | Baker McKenzie | Partner | Employment | San Francisco |
| Xin Tao | Baker McKenzie | Partner | FDA Regulation | Washington D.C. |
| Lois Sheng Liu | Baker McKenzie | Associate | FDA Regulation | Washington D.C. |
| Roberta Lynn Turner | Baker McKenzie | Associate | FDA Regulation | Dallas |
| Lane Morgan | Baker McKenzie | Partner | Tax | Dallas |
| Jessica Wicha | Baker McKenzie | Counsel | Environmental | Chicago |
| Sarah Swain | Baker McKenzie | Associate | Real Estate | San Francisco |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Lotus Pharmaceutical Co. Ltd.Buy-side
- Counterparties
- New Alvogen Group Holdings, Inc. (Sell-side)